Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy of Nivolumab As Checkpoint Inhibitor Drug on Survival Rate of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma: A Meta-Analysis of Prospective Clinical Study
Mohsen Nikbakht
Mohsen Nikbakht

Associate Professor of Medical Biotechnology

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

All Documents
17. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (Aml)?, International Journal of Hematology-Oncology and Stem Cell Research (2022)
24. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
26. Effects of Mobilized Peripheral Blood Stem Cells on Treatment of Primary Lower Extremity Lymphedema, Journal of Vascular Surgery: Venous and Lymphatic Disorders (2020)
32. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of Hcc, Evidence-based Complementary and Alternative Medicine (2020)
48. Anti-Apoptotic Effects of Osteopontin Via the Up-Regulation of Akt/Mtor/Β-Catenin Loop in Acute Myeloid Leukemia Cells, International Journal of Hematology-Oncology and Stem Cell Research (2017)